Adam Raymakers

7PUBLICATIONS
15CO-AUTHORS
Major global burdens of diseaseHaematological tumoursChemotherapyRadiation therapyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 03, 2026
Health-related quality of life measures in incarcerated populations: a scoping review.

|Jul 11, 2023
High Cost of Chimeric Antigen Receptor T-Cells: Challenges and Solutions.

Edward R Scheffer Cliff, Amar H Kelkar, David A Russler-Germain

|Feb 08, 2022
Qualitative Research Informing a Preference Study on Selecting Cannabis for Cancer Survivor Symptom Management: Design of a Discrete Choice Experiment.

Colene Bentley, Sara Izadi-Najafabadi, Adam Raymakers

|Jun 02, 2021
Cost-Effectiveness Analysis of Stereotactic Ablative Body Radiotherapy for the Treatment of Oligometastatic Tumors versus Standard of Care.

Adam J N Raymakers, David Cameron, Scott Tyldesley

|Jan 19, 2021
Early-Phase Clinical Trials and Reimbursement Submissions to the Pan-Canadian Oncology Drug Review.

Adam J N Raymakers, Kristina M Jenei, Dean A Regier

|Oct 14, 2020
Cost-effectiveness of brentuximab vedotin in advanced stage Hodgkin's lymphoma: a probabilistic analysis.

A J N Raymakers, S Costa, D Cameron

Pageof 2

Frequent Collaborators

1 joint publications

David Cameron

1 joint publications

Edward R Scheffer Cliff

1 joint publications

Amar H Kelkar

1 joint publications

David A Russler-Germain